Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury

US10626071B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10626071-B2
Application numberUS-201815961085-A
CountryUS
Kind codeB2
Filing dateApr 24, 2018
Priority dateFeb 10, 2011
Publication dateApr 21, 2020
Grant dateApr 21, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: a compound having the formula: wherein R is S; R1 is —OR5 where R5 is H or CH 3 ; R2 is phenyl; and R3 is 3 methylene groups, or a pharmaceutically acceptable salt thereof, in an amount effective to increase renal progenitor cell production in a kidney of a patient; and a pharmaceutically-acceptable excipient. 2. The composition of claim 1 , wherein the compound has the formula: or a pharmaceutically acceptable salt thereof. 3. The composition of claim 1 , comprising a cyclodextrin complexed with the compound. 4. The composition of claim 1 , wherein the compound is 4-(phenylthio)butanoic acid. 5. A method, comprising administering the composition of claim 1 to a subject. 6. A method, comprising administering the composition of claim 2 to a subject. 7. A method, comprising administering the composition of claim 3 to a subject. 8. A method, comprising administering the composition of claim 4 to a subject. 9. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 1 to the patient. 10. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 2 to the patient. 11. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 3 to the patient. 12. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 4 to the patient.

Assignees

Inventors

Classifications

  • the carbon skeleton containing six-membered aromatic rings · CPC title

  • having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton · CPC title

  • of the kidneys · CPC title

  • Simulated moving beds · CPC title

  • the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10626071B2 cover?
Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.
Who is the assignee on this patent?
Univ Of Pittsburgh—Of The Commonwealth System Of Higher Education
What technology area does this patent fall under?
Primary CPC classification B01D15/1821. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).